kw 5092 has been researched along with loperamide in 1 studies
Studies (kw 5092) | Trials (kw 5092) | Recent Studies (post-2010) (kw 5092) | Studies (loperamide) | Trials (loperamide) | Recent Studies (post-2010) (loperamide) |
---|---|---|---|---|---|
14 | 0 | 0 | 1,358 | 196 | 488 |
Protein | Taxonomy | kw 5092 (IC50) | loperamide (IC50) |
---|---|---|---|
Cocaine esterase | Homo sapiens (human) | 5.7 | |
Beta-2 adrenergic receptor | Homo sapiens (human) | 3.005 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 2.5 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 9.27 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 2 | |
Histamine H2 receptor | Homo sapiens (human) | 3.081 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 2.202 | |
Mu-type opioid receptor | Homo sapiens (human) | 0.0014 | |
D(3) dopamine receptor | Homo sapiens (human) | 1.337 | |
Delta-type opioid receptor | Homo sapiens (human) | 0.896 | |
Kappa-type opioid receptor | Homo sapiens (human) | 3.125 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 4.105 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.033 | |
Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 0.239 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.628 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishii, A; Karasawa, A; Kishibayashi, N; Takasaki, K | 1 |
1 other study(ies) available for kw 5092 and loperamide
Article | Year |
---|---|
Effects of KW-5092, a novel gastroprokinetic agent, on the delayed colonic propulsion in rats.
Topics: Animals; Clonidine; Colon; Dose-Response Relationship, Drug; Gastrointestinal Motility; Imidazoles; Loperamide; Male; Nitriles; Rats; Rats, Sprague-Dawley; Stimulation, Chemical | 1994 |